Ignacio Sanz
Rheumatology · Rochester, NYNPI 1780601872
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $64,402 of the $67,750 with a category attached, or 95.1%. 10 manufacturers reported payments, led by GSK at 33.4% of the total. Among rheumatology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 42 payments — averaging $1613.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$23K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$16K
- E.r. Squibb & Sons, L.L.C.$9K
- Novartis$7K
- Janssen Research & Development, LLC$5K
- Merck$4K
- plus $4K from 4 others
Across 11 payments — averaging $121,363 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$1.3M
- AstraZeneca$27K
What the payments were for
- Consulting fees$64,40295%
- Travel & lodging$2,1323%
- Food & beverage$1,1632%
- Education$530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 13 | $22,634 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 10 | $16,342 |
| E.r. Squibb & Sons, L.L.C. | 4 | $9,380 |
| Novartis | 6 | $6,526 |
| Janssen Research & Development, LLC | 1 | $4,500 |
| Merck | 1 | $4,185 |
| Otsuka Pharmaceutical Co., Ltd. | 3 | $2,246 |
| Sanofi US Services Inc. | 1 | $1,823 |
| Bristol Myers Squibb | 2 | $60 |
| Genentech, Inc. | 1 | $53 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$67,750 in reported general payments places this provider in the 90th percentile of 541 rheumatology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 50 | $1,233 |
| Azathioprine | 15 | $215 |
| Methylprednisolone | 13 | $109 |
| Prednisone | 17 | $91 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Rochester
- Christopher RitchlinRochester$349K
- Laurie GlimcherNew York$3.9M
- Grace WrightNew York$3M
- Kostas BotsoglouCheektowaga$2.6M
- Sergio SchwartzmanNew York$2.5M
- Allan GibofskyNew York$1.9M
- Petros EfthimiouNew York$791K
- Richard FurieNew Hyde Park$746K
- Barry GruberBabylon$742K
- Olga PetrynaNew York$509K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.